BioMedNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Targeted ‘Finish Line Is Within Sight’ as It Pursues Potential GBM Treatment
Nov 7, 2022
CNS Pharmaceuticals (NASDAQ: CNSP) has been developing drug candidates for treating primary and metastatic brain and central nervous system cancer. “Berubicin, the company’s lead drug candidate, is a novel anthracycline in an ongoing international trail in glioblastoma (“GBM”) treatment. The interim analysis data from this potentially pivotal trial is expected in mid-2023… Berubicin was the first [anthracycline] to provide scientific data which appears to demonstrate its ability to cross the blood-brain barrier and was designed with a molecular target of topoisomerase II enzymes responsible for cleaving and recombing double-stranded DNA during cellular replication,” a recent article explains. “Since the beginning of 2022, CNS Pharmaceuticals has completed pivotal milestones with Berubicin, receiving approval from Switzerland Ethics Committee (‘EC’) and Competent Authority (‘CA’), France EC and CA, and Spain EC and CA to open sites. The company’s next steps include pivotal trial expansions into additional countries, expected completion of enrollment, interim analysis/data, and target topline results from the potentially pivotal study… ‘We are at the point where the finish line is within sight, and that is: ‘Is this drug performing in a clinical setting the way we want it to?’ And if it is, there is nothing to compete with it,’ CNS Pharmaceuticals CEO John Climaco commented.”
To view the full article, visit https://ibn.fm/Fu0ZL
About CNS Pharmaceuticals Inc.
CNS Pharmaceuticals is a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic cancers of the brain and central nervous system. The company’s lead drug candidate, Berubicin, is a novel anthracycline and the first anthracycline to appear to cross the blood-brain barrier. Berubicin is currently in development for the treatment of a number of serious brain and CNS oncology indications including glioblastoma multiforme (“GBM”), an aggressive and incurable form of brain cancer. Additionally, the company is advancing the development of its WP1244 drug technology portfolio, which utilizes anthracycline and distamycin-based scaffolds to create small molecule agents and is believed to be 500x more potent than daunorubicin in inhibiting tumor cell proliferation. Preclinical studies of WP1244 demonstrated high uptake in the brain with antitumor activity. CNS Pharmaceuticals is evaluating the use of the WP1244 portfolio in the treatment of brain cancers, pancreatic, ovarian, and lymphomas. For more information, visit the company’s website at www.CNSPharma.com.
NOTE TO INVESTORS: The latest news and updates relating to CNSP are available in the company’s newsroom at https://ibn.fm/CNSP
About BioMedWire
BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)
For more information please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]
BioMedWire is part of the InvestorBrandNetwork
More News
/file/publisher-c1a3f893382d2b2f8a9aa22a654d9c97/2020/08/02cbe25eab1d7eddf301e478998b7b86.jpg)
Nearly 100 Media Mulia employees to be placed under paid leave programme
'Rationalisation exercise to ensure continuity, sustainability of the business.'
Malaysia Airlines becomes latest carrier hit by Amadeus booking system data breach
Malaysia Airlines said Sunday that some customer information may have been compromised in a cybersecurity incident involving Amadeus, a global travel technology provider based in Spain whose systems support airline reservations and passenger services.
Bicam talks on 2027 budget to be opened to CSOs -- JV Ejercito
Senate finance committee chairperson JV Ejercito has committed to inviting civil society organizations (CSOs) to observe the bicameral conference committee deliberations on the proposed P7.2-trillion national budget for fiscal year 2027.
House spends P100M a year on utilities. Why ask for P1B?
In 2025, the House secured a billion pesos for the chamber's water and electricity expenses, even though it historically spent only a small fraction of that amount annually. Where did the money go?
Jet nosedives, erupts into fireball near South Florida busy roadway, killing all 9 on board
A business jet carrying nine people nose-dived into a South Florida neighborhood Sunday and erupted into a giant fireball that appeared to just miss homes near a busy roadway. Everyone on board was killed, the nation's transportation secretary said.
LIST: Flights canceled, rescheduled due to ASEAN November 2026 summit
The Civil Aeronautics Board advises the public 'to closely monitor the status of their flights, including any official government and airline advisories for travel updates and coordinate directly with their airlines for any alternative options'
_2026_11_02_09_07_13.jpg)
For her Halloween 2026 costume, Andrea Brillantes dresses up as a dream'
Andrea Brillantes has quite the Halloween costume for 2026, dressing as a, ehem, dream.
_2026_11_02_08_39_19.jpg)
Your Horoscopes for Nov. 2-8, 2026: Why Nov. 4 is the day to watch
Wednesday, November 4 is the highlight of the week. It brings two major astrological events that could change how you see a situation and bring better prospects for love, money, and work.
Nearly 1.2 million passengers monitored at ports so far amid Undas 2026 --PCG
The Philippine Coast Guard has monitored nearly 1.2 million passengers at ports nationwide as of Monday morning, November 2, amid the influx of travelers during the Undas 2026 long weekend.
Baguio council seeks report on P225-M Camp John Hay claim vs BCDA
BAGUIO CITY, Philippines — The city council is seeking a detailed accounting of Camp John Hay‘s business tax collections and the city’s estimated P225-million claim for unpaid rentals and revenue shares from the property. In a statement Sunday (Nov. 1), the city council discussed the matter during its recent regular session, when Councilor Leandro Yangot
3 marijuana plantations destroyed in Benguet
BAGUIO CITY, Philippines — Police discovered three marijuana plantations in the towns of Kapangan and Kibungan in Benguet, and seized plants and seedlings with an estimated street value of P270,000 during eradication operations on Friday, Oct. 30. In a statement, the Police Regional Office-Cordillera (PRO-CAR) said the plantations were found in Barangay Sagubo in Kapangan
/file/publisher-c1a3f893382d2b2f8a9aa22a654d9c97/2023/03/3440b83dbb75ecd043e24b5564828303.jpg)
750 doctor posts for Sabah, Sarawak – but who will take entry-level pay grade?
Groups warn low pay may deter experienced doctors from returning to serve.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.